For the quarter ending 2026-03-31, PMN has $67,411,571 in assets. $6,693,999 in debts. $63,814,345 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 63,814,345 | 6,116,556 | 15,399,165 | 4,510,119 |
| Short-term investments | 33,753 | 33,753 | 33,051 | 33,051 |
| Prepaid expenses and other current assets | 1,764,594 | 3,032,112 | 6,025,931 | 4,966,326 |
| Total current assets | 65,612,692 | 9,182,421 | 21,458,147 | 9,509,496 |
| Prepaid expenses, long-term | 1,798,879 | - | - | - |
| Total assets | 67,411,571 | 9,182,421 | 21,458,147 | 9,509,496 |
| Accounts payable | 1,716,823 | 2,543,415 | 4,211,485 | 2,780,179 |
| Accrued liabilities | 4,897,796 | 7,868,416 | 7,999,562 | 7,043,908 |
| Total current liabilities | 6,614,619 | 10,411,831 | 12,211,047 | 9,824,087 |
| Warrant liability | - | - | 5,592 | 5,592 |
| Share-based compensation liability | 79,380 | 29,182 | 54,153 | 62,395 |
| Common shares, no par value, unlimited shares authorized, 32,689,190 shares issued and outstanding as of june 30, 2025 and december 31, 2024 | - | - | - | 0 |
| Total liabilities | 6,693,999 | 10,441,013 | 12,270,792 | 9,892,074 |
| Additional paid-in capital | 199,739,348 | 129,518,812 | 129,290,671 | 108,140,611 |
| Accumulated other comprehensive loss | -371,184 | -371,184 | -371,184 | -371,184 |
| Accumulated deficit | -138,650,592 | -130,406,220 | -119,732,132 | -108,152,005 |
| Total shareholders' equity | 60,717,572 | -1,258,592 | 9,187,355 | -382,578 |
| Total liabilities and shareholders' equity | 67,411,571 | 9,182,421 | 21,458,147 | 9,509,496 |
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)